Schedule 13G ownership disclosure

ARS Pharmaceuticals Inc

Common Stock, par value $0.0001 per share · CUSIP: 82835W108

Event date: 2026-03-17

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Millennium Management LLC

    Shares: 5,391,440.00 · Class: 5.4%

  • Millennium Group Management LLC

    Shares: 5,391,440.00 · Class: 5.4%

  • Israel A. Englander

    Shares: 5,391,440.00 · Class: 5.4%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-26-033875
Form type
SCHEDULE 13G
Filer
ARS Pharmaceuticals, Inc.
CIK
CIK 1671858
Filed
Mar 24, 2026
Reporting period
Mar 17, 2026
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub